Stock Update (NASDAQ:ILMN): Illumina, Inc. Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa

Illumina, Inc. (NASDAQ:ILMN) announced that it has appointed Paula Dowdy to lead theEurope, Middle East and Africa (EMEA) commercial team as Senior Vice President and General Manager. Paula was previously Senior Vice President for Cloud, Software, and Managed Services at Cisco.

“We are truly excited for Paula to lead our EMEA commercial operations team,” said Christian Henry, Executive Vice President for Commercial Operations. “Paula brings a proven track record of leadership, insight and execution, and her passion for delivering customer success will serve the EMEA region exceptionally well. Additionally, this hire supports our strategy to bring in expertise from large-scale companies to complement our leadership team.”

Paula joined Cisco 20 years ago and has spent the majority of her career in Europe. She has held numerous senior positions leadingCisco product and services groups for virtually all customer segments. In her most recent role, Paula led Cisco’s go-to-market team for Cloud, Software, and Managed Services where she drove the incubation of innovative new solutions.

Paula holds an MBA degree from Pepperdine University and a Bachelor of Arts degree from the University of California, Berkeley. Paula will officially join Illumina August 1, 2016. (Original Source)

Shares of Illumina closed yesterday at $145.78, up $0.95 or 0.66%. ILMN has a 1-year high of $242.37 and a 1-year low of $127.10. The stock’s 50-day moving average is $143.97 and its 200-day moving average is $160.18.

On the ratings front, Illumina has been the subject of a number of recent research reports. In a report issued on May 23, Leerink Swann analyst Dan Leonard reiterated a Hold rating on ILMN, with a price target of $145, which represents a slight downside potential from current levels. Separately, on May 4, Cantor Fitzgerald’s Bryan Brokmeier reiterated a Hold rating on the stock and has a price target of $165.

According to, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Dan Leonard and Bryan Brokmeier have a total average return of 2.6% and 6.7% respectively. Leonard has a success rate of 52% and is ranked #1275 out of 3,986 analysts, while Brokmeier has a success rate of 56% and is ranked #601.

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function. The company provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. 


Stay Ahead of Everyone Else

Get The Latest Stock News Alerts